Hospitalist · Pembroke Pines, FL
NPI
1962645671
Since 2009
Specialty
Hospitalist
Code 208M00000X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
1620 NW 122nd Ave
Pembroke Pines, FL, 33026
Phone (954) 895-5729
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
256 services
Medicare patients, 2024
88
Average age 75
Drug cost, 2024
$16.5M
74,666 prescriptions
Company payments, 2023
$21.96
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vince Faridani was code 99232 (hospital e&m - subsequent), 148 times for 61 patients. In total Vince Faridani billed 256 services in 7 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 148 | 61 | $59.12 | $8,749 |
| 99233 Hospital E&M - Subsequent | Facility | 73 | 36 | $86.16 | $6,290 |
| 99239 Hospital Discharge Management | Facility | 20 | 20 | $84.69 | $1,694 |
By year: 2022 $53K for 749 services; 2023 $41K for 524 services; 2024 $18K for 256 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vince Faridani prescribed most often to Medicare patients was Arexvy (Rsvpref3 Antigen/As01e/Pf), with 30,237 prescriptions and refills. In total Vince Faridani wrote 74,666 Medicare prescriptions that cost $16.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Arexvy Rsvpref3 Antigen/As01e/Pf | 30,237 | 30,237 | 30,134 | $8.3M |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 28,143 | 28,143 | 21,803 | $5.5M |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 7,320 | 7,322 | 7,260 | $454K |
| Abrysvo Rsv Vacc, Pref A And Pref B/Pf | 7,203 | 7,203 | 7,194 | $2.0M |
| Twinrix Hepatitis A And B Vaccine/Pf | 1,039 | 1,039 | 750 | $133K |
| Havrix Hepatitis A Virus Vaccine/Pf | 173 | 173 | 159 | $17K |
| Gardasil 9 Hpv Vaccine 9-Valent/Pf | 137 | 137 | 109 | $37K |
| Tenivac Tetanus-Diphtheria Toxoids/Pf | 134 | 134 | 134 | $7,079 |
| M-M-R Ii Vaccine Measles,mumps,rubella Vacc/Pf | 65 | 65 | 61 | $6,803 |
| Priorix Measles,mumps,rubella Vacc/Pf | 31 | 31 | 31 | $3,011 |
| Menquadfi Mening Vac A,c,y,w135,c-Tet/Pf | 26 | 26 | 24 | $4,872 |
| Tdvax Tetanus, Diphtheria Tox,adult | 22 | 22 | 22 | $889 |
| Heplisav-B Hepatitis B Vaccine/Cpg1018/Pf | 21 | 21 | 15 | $3,259 |
| Vaqta Hepatitis A Virus Vaccine/Pf | 13 | 13 | 11 | $1,226 |
| Jynneos Smallpox And Mpox Live Vacc/Pf | 13 | 13 | 12 | $2,837 |
Brand drugs: 74,624 claims; generic drugs: 42 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Vince Faridani $21.96 ($21.96 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $21.96.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $21.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.